Loading Stress Analysis of Cement Concrete Pavement in Mountainous Areas

The suitable cement concrete pavement for mountainous areas is a form of low-cost cement concrete pavement that uses unconventional graded stones in different proportions in ordinary concrete,allowing the concrete to fully contact the stones and form a stable and well-bonded slab with large particle stones.As large particle stones replace a certain volume of cement concrete,they have good economic performance and are a low-cost form of cement concrete pavement.This study researches the use of ANSYS tools to analyze the influence of geometric dimensions and material properties of rigid pavement structural layers on the mechanical properties of pavement structures.

不同交联层厚度的聚丙烯酸酯乳液的制备及压敏性能

通过调控增长阶段交联剂参与反应的时间,采用半连续种子乳液聚合方法制备了一系列固含量为50%,乳胶粒粒径相同但交联层厚度不同的聚丙烯酸酯乳液。采用动态光散射、凝胶渗透色谱和动态力学热分析等手段,考察了交联层厚度对乳液聚合过程、聚合物分子结构及分子运动的影响。结果表明,交联层厚度对聚合过程和乳液稳定性没有明显影响;随着交联层厚度的增加,聚合物的凝胶含量和储能模量增加,可溶部分相对分子质量和缠结相对分子质量减小。依据FINAT标准测试了该乳液压敏胶的初黏力、剥离力和耐持黏性。控制交联层厚度在合适范围,可得到压敏性能均衡的乳液。

双钙钛矿Zn2FeTaO6电子结构和自发电极化的第一性原理研究

基于第一性原理方法,我们研究了双钙钛矿Zn2FeTaO6的晶体结构、电子结构、以及铁电性质。计算结果表明Zn2FeTaO6中的Zn2+离子,Fe3+离子和Ta5+离子均偏离氧八面体的中心。同时,基于线性响应理论Born有效电荷计算显示其自发电极化强度为79.6 μC/cm2。我们还利用杂化泛函理论进一步研究了Zn2FeTaO6的能带结构,发现带隙宽度约为2.6 eV,与多铁材料BiFeO3接近,显示Zn2FeTaO6在铁电光伏领域的潜在应用。

Drug-loaded balloon with built-in NIR controlled tip-separable microneedles for long-effective arteriosclerosis treatment

Drug-eluting balloon(DEB)angioplasty has emerged as an effective treatment for cardiovascular and cerebrovascular diseases.However,distal embolism and late lumen restenosis could be caused by drug loss during DEB handling and rapid drug metabolization.Here,a drug-loaded balloon equipped with tip-separable microneedles on the balloon surface(MNDLB)was developed.Inbuilt near-infrared(NIR)ring laser inside the catheter inner shaft was introduced to activate the biodegradable microneedle tips for the first time.The drug-loaded tips thus could be embedded in the vasculature and then released antiproliferative drug-paclitaxel slowly via polymer degradation for more than half a year.A significant increase in drug delivery efficiency and superior therapeutic effectiveness compared with the standard DEB were demonstrated using an atherosclerosis rabbit model.

Terbium-doped zinc oxide constructed dual-light-responsive nitric oxide-releasing platform for bacterial keratitis treatment

Bacterial keratitis(BK)is a principal factor contributing to corneal ulcers and ocular complications,and has become a significant killer of global vision health.Traditional antibiotic therapy has unsatisfactory therapeutic effect due to short residence time and low utilization rate of drug,and the long-term abuse of antibiotics can easily incur the prevalence of drug-resistant bacteria.Furthermore,antibiotics are not effective in addressing the excessive inflammatory response caused by infection.Here,we developed a terbium-doped zinc oxide constructed dual-light-responsive nitric oxide(NO)-releasing nanoparticle(ZT@P@B)and modified it on the surface of contact lenses(CL-ZT@P@B)to boost its bioavailability.In vitro and in vivo experimental results verified that ZT@P@B could simultaneously respond to green light(GL)and 808 nm near-infrared(NIR)without obvious damage to the eyes,releasing reactive oxygen species(ROS)and NO,which could effectively kill bacteria(including drug-resistant strains)and reduce inflammatory response.The platform provides a promising strategy for the prevention and treatment of BK.

Upconversion nanoparticles regulated drug&gas dual-effective nanoplatform for the targeting cooperated therapy of thrombus and anticoagulation

Thromboembolism is the leading cause of cardiovascular mortality.Currently,for the lack of targeting,short half-life,low bioavailability and high bleeding risk of the classical thrombolytic drugs,pharmacological thrombolysis is usually a slow process based on micro-pumping.In addition,frequently monitoring and regulating coagulation functions are also required during(and after)the process of thrombolysis.To address these issues,a targeted thrombolytic and anticoagulation nanoplatform(UCATS-UK)is developed based on upconversion nanoparticles(UCNPs)that can convert 808 or 980 nm near-infrared(NIR)light into UV/blue light.This nanoplatform can target and enrich in the thrombus site.Synergistic thrombolysis and anticoagulation therapy thus could be realized through the controlled release of urokinase(UK)and nitric oxide(NO).Both in vitro and in vivo experiments have confirmed the excellent thrombolytic and anticoagulative capabilities of this multifunctional nanoplatform.Combined with the unique fluorescent imaging capability of UCNPs,this work is expected to contribute to the development of clinical thrombolysis therapy towards an integrated system of imaging,diagnosis and treatment.

Yellow responsive material based modification to reduce earphone induced Infection and hearing loss

Today,earphones have almost been owned by everyone.However,wearing earphones for a long time can cause two serious problems:(1)irreversible damage to hearing;(2)rapid proliferation of bacteria in the ear canal.Herein,an earphone modification strategy is developed for the first time,to reduce hearing loss and inhibit bacteria simultaneously.This earphone is equipped with a high purity yellow light(YL)light-emitting diode chip developed by our university.Then,the surface of the earphone is loaded with porous zinc oxide and silver nanoparticle composite material(ZnO-Ag)that can respond to the YL.Under the excitation of YL,the porous ZnO-Ag can release reactive oxygen species with strong antibacterial activity.More importantly,we discover that YL can reduce the expression of matrix metalloproteinase-3,the secretion of inflammatory factors,and apoptosis in the cochlea,thereby effectively reduce hearing loss.